Stocks · Korea
061250
KOSDAQ
Hwail Pharm
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W-0.77%
1M-29.92%
3M-24.41%
6M-35.28%
1Y-46.11%
YTD-44.72%
52W high13,800원
52W low6,210원
From 52W high-53.33%
Financial results (separate)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 1,321억 | 48억 | -63억 | 3.6% |
| 2023 | 1,225억 | 20억 | 39억 | 1.7% |
| 2024 | 1,198억 | 8억 | 65억 | 0.6% |
| 2025 | 1,008억 | -23억 | -2억 | -2.3% |
| Quarterly | ||||
| 2024 4Q | 266억 | -4억 | 58억 | -1.5% |
| 2025 1Q | 300억 | -12억 | -7억 | -4.0% |
| 2025 2Q | 280억 | 50,913,808원 | 6억 | 0.2% |
| 2025 3Q | 243억 | 2억 | 4억 | 0.7% |
| 2025 4Q | 186억 | -13억 | -5억 | -7.0% |
| 2026 1Q | 234억 | -6억 | 6억 | -2.4% |
Company
Address: 경기도 평택시 산단로 241 -
Peers in the same sector
Recent filings
- 2026-10-02[기재정정]주요사항보고서(전환사채권발행결정) Major
- 2026-09-15주요사항보고서(전환사채권발행결정) Major
- 2026-09-15주요사항보고서(유상증자결정) Major
- 2026-08-13반기보고서 (2026.06)
- 2026-05-15분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.